Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

anti-Cyclin D1/Bcl-1, Clone: SP4, Epredia™ LabVision

The Epredia™ Cyclin D1/Bcl-1, Rabbit Monoclonal Antibody is part of a comprehensive antibody portfolio. Studies show rabbit monoclonal antibodies are more sensitive and specific than other available markers.

Supplier:  Epredia RM9104R7

Catalog No. RM9104R7


Description

Description

Cyclin D1 or PRAD-1 or bcl-1 is one of the key cell cycle regulators, and functions in association with cdk4 and/or cdk6 by phosphorylating the Rb protein. It is a putative proto-oncogene overexpressed in a wide variety of human neoplasms including mantle cell lymphomas (MCL).

Host Species: Rabbit
Clone: SP4
Isotype: IgG
Species Reactivity: Human, Mouse, Rat. Others not tested.
Epitope: C-terminus
Immunogen: A synthetic peptide from C-terminus of human cyclin D1
Molecular Weight: 36kDa
Positive Control: MAD109 cells, breast CA or mantle cell lymphoma
Cellular Localization: Nuclear

Clone SP4 is excellent for staining of formal/paraffin tissue.

†USA: IVD; Int'l: IVD

Immunohistochemistry (Paraffin), Western Blotting

Specifications

Specifications

Cyclin D1/Bcl-1
SP4
Unconjugated
A synthetic peptide from C-terminus of human cyclin D1
IVD
Primary
Prediluted
Monoclonal
n/a
Rabbit
7 mL
Cell Cycle
Human, Mouse, Rat
IgG
Product Suggestions

Product Suggestions

Videos
Safety and Handling

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.